Absolutely best possible outcome , adult trial is likely to get the green light too… resubmission and AA for LVAD… very interesting end of 2024 and start of 2025
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-73
-
- There are more pages in this discussion • 1,024 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.10 |
Change
-0.003(0.23%) |
Mkt cap ! $1.250B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.11 | $1.08 | $1.256M | 1.158M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 36712 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 128874 | 20 |
View Market Depth
| Last trade - 11.50am 19/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |